Cornerstone Select Advisors’s Amgen AMGN Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$1.54M Buy
4,384
+317
+8% +$113K 0.97% 37
2025
Q4
$1.33M Buy
4,067
+137
+3% +$43.5K 0.92% 37
2025
Q3
$1.11M Buy
3,930
+324
+9% +$94K 0.82% 41
2025
Q2
$1.01M Buy
3,606
+13
+0.4% +$3.68K 0.89% 40
2025
Q1
$1.12M Buy
3,593
+446
+14% +$132K 1.06% 35
2024
Q4
$820K Buy
+3,147
New +$934K 0.79% 41

Other funds holding AMGN

Cornerstone Select Advisors's AMGN Position: Q1 2026 in Review

Cornerstone Select Advisors increased its Amgen (AMGN) stake by 7.8% in Q1 2026, buying an estimated $113K and bringing the position to 4,384 shares worth $1.54M. The position accounts for 0.97% of the portfolio, ranked #37.

Cornerstone Select Advisors first reported a position in AMGN in Q4 2024 and has held it in 6 quarters since. 3,128 funds tracked by Wall St. Rank hold AMGN as of Q1 2026.

  • Cornerstone Select Advisors held 4,384 shares of Amgen worth $1.54M as of Q1 2026.
  • Cornerstone Select Advisors bought 317 Amgen shares in Q1 2026, an estimated $113K.
  • Amgen made up 0.97% of Cornerstone Select Advisors's portfolio in Q1 2026, its #37 holding.
  • Cornerstone Select Advisors first reported a position in Amgen in Q4 2024 and has held it in 6 quarters since.
  • 3,128 funds tracked by Wall St. Rank held Amgen as of Q1 2026.

Based on Cornerstone Select Advisors's 13F filing for Q1 2026, filed 13 May 2026.